Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Digital Health Center of Excellence

Digital Health Center of Excellence

                        Cybersecurity in Medical Devices Frequently Asked Questions (FAQs)
          Digital Health Frequently Asked Questions (FAQs)
          Digital Health Center of Excellence Services
          About the Digital Health Center of Excellence
          Network of Digital Health Experts
          What is Digital Health?
          Cybersecurity
          Digital Health Terms
          Guidances with Digital Health Content
          Digital Health Policy Navigator
          Digital Health Reports
          FDA Digital Health Advisory Committee
          Medical Device Interoperability
          Digital Health Research and Partnerships
          Augmented Reality and Virtual Reality in Medical Devices


                        Diagnostic Data Program
          Software as a Medical Device (SaMD)
          Device Software Functions Including Mobile Medical Applications
          Wireless Medical Devices
          Digital Health Software Precertification (Pre-Cert) Pilot Program Home
          Medical Devices
          Digital Health Center of Excellence
          Blog: Digital Health Collaboration Fosters Innovation and Health EquityDigital Health Center of Excellence Blog: Digital Health Collaboration Fosters Innovation and Health Equity
  
  	
    Share
    Post
    Linkedin

    Email
    PrintImage
              Image of a woman holding a smart tablet.*By: Troy Tazbaz, Director, Digital Health Center of Excellence, Center for Devices and Radiological Health, U.S. Food and Drug Administration*

Troy Tazbaz, Director, Digital Health Center of Excellence
Troy Tazbaz, Director, Digital Health Center of ExcellenceOne of my highest priorities for the Digital Health Center of Excellence (DHCoE) is to foster collaboration as we seek to understand and assess the rapid advances occurring in the digital health ecosystem. I see patients, researchers, health care providers, medical product manufacturers, technology companies, standards organizations, and many other stakeholders as playing integral roles in advancing digital health, and ultimately improving health care.

Our collective sharing of knowledge can increase awareness of digital health advancements and reveal opportunities for synergy. DHCoE's collaborative regulatory science research in the areas of artificial intelligence/machine learning (AI/ML), digital biomarkers, and digital health technologies continues to demonstrate how we can advance responsible innovation together.

The Opportunity for Digital Health to Improve Diabetes Prevention and Early Detection

Today I want to share with you an area of interest and an opportunity for digital health collaboration that touches the lives of so many people: diabetes.****One in 10 Americans has diabetes—37 million people—and one in five do not know they have it. As President Biden's proclamation for National Diabetes Month recommits us as a nation to do more to prevent and manage this disease, we at the DHCoE are asking, "What role can digital health technology play?"

With this ability to facilitate prevention, early diagnosis, and management of chronic conditions outside of traditional health care settings, digital health technologies (DHTs) also have the potential to reach underserved populations and advance health equity. There are many examples of socioeconomically disadvantaged or geographically isolated communities that lack access to health care services and have a higher risk of developing diabetes or diabetes-related complications. This highlights the opportunity for digital health to identify diabetes earlier and to help people live healthier lives.

Together—as the whole of government and as a community of researchers and innovators—we can work hand in hand with the people most impacted by type 2 diabetes to extend the reach of the health care system beyond the clinic, and to advance the use of DHTs to help people better measure, understand, and manage their health.

We need your help. CDRH previously announced that we are seeking comment from the public on a number of questions related to diabetes prevention and detection, and a docket is open for the public to submit comments. Please share your insights on how digital health technologies may help with early detection of risk factors for type 2 diabetes, prediabetes, and type 2 undiagnosed diabetes now through January 31, 2024. We invite you to answer these and other important questions:

How can DHTs extend care into people's homes and communities, to play a role in early detection, prevention, or disease reversal of type 2 diabetes?
	How can DHTs be used to advance health equity and help people in impacted communities avoid the burden and disability from diabetic-related conditions such as blindness or stroke, and cardiovascular, kidney, and peripheral vascular disease?This is our opportunity to make significant strides in advancing safe and effective DHTs and reducing the diabetes epidemic's effect on individuals and society.

Opportunities to Collaborate with the DHCoE

I welcome you to collaborate with our DHCoE through our ongoing regulatory science research projects, as well as our Centers of Excellence in Regulatory Science and Innovation (CERSI), and Collaborative Communities, in which private- and public-sector members work together on medical device challenges.

We are here to help you navigate the FDA's current policies on digital health products and to provide informal feedback on the possible regulatory status of products in development. We welcome your questions and look forward to your continued partnership.

                                                                                  Content current as of:
      01/09/2024
              
              
Regulated Product(s)
		 Medical DevicesDigital Health Center of Excellence

          
                        Cybersecurity in Medical Devices Frequently Asked Questions (FAQs)
          Digital Health Frequently Asked Questions (FAQs)
          Digital Health Center of Excellence Services
          About the Digital Health Center of Excellence
          Network of Digital Health Experts
          What is Digital Health?
          Cybersecurity
          Digital Health Terms
          Guidances with Digital Health Content
          Digital Health Policy Navigator
          Digital Health Reports
          FDA Digital Health Advisory Committee
          Medical Device Interoperability
          Digital Health Research and Partnerships
          Augmented Reality and Virtual Reality in Medical Devices


                        Diagnostic Data Program
          Software as a Medical Device (SaMD)
          Device Software Functions Including Mobile Medical Applications
          Wireless Medical Devices
          Digital Health Software Precertification (Pre-Cert) Pilot Program
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop